Tag:
isavuconazole
Latest Headlines
Latest Headlines
Basilea sees another ceftobiprole rejection, isavuconazole delay
Swiss biotech Basilea Pharmaceutica saw its shares decline Friday after the European Committee for Medicinal Products for Human Use confirmed its previous negative opinion on the marketing
Basilea lands $510M co-marketing pact with Astellas
Switzerland's Basilea nailed a $510 million co-marketing pact with Astellas Pharma, hauling in a $70 million upfront payment and gaining a partner who will take over Phase III development of the
